학술논문

Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy. (Biomedicine and Pharmacotherapy, June 2024, 175)
Subject
Language
English
ISSN
19506007
07533322